PMC:7200337 / 11403-13171
Annnotations
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32505227-26867177-46575246 | 475-479 | 26867177 | denotes | 2016 |
32505227-26867177-46575247 | 644-648 | 26867177 | denotes | 2016 |
32505227-30761102-46575248 | 1039-1043 | 30761102 | denotes | 2019 |
32505227-26331680-46575249 | 1066-1070 | 26331680 | denotes | 2015 |
32505227-31231549-46575250 | 1084-1088 | 31231549 | denotes | 2019 |
32505227-31034780-46575251 | 1102-1106 | 31034780 | denotes | 2019 |
T64773 | 475-479 | 26867177 | denotes | 2016 |
T66903 | 644-648 | 26867177 | denotes | 2016 |
T63051 | 1039-1043 | 30761102 | denotes | 2019 |
T37267 | 1066-1070 | 26331680 | denotes | 2015 |
T42183 | 1084-1088 | 31231549 | denotes | 2019 |
T82803 | 1102-1106 | 31034780 | denotes | 2019 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T89236 | 738-747 | Body_part | denotes | epithelia | http://purl.org/sig/ont/fma/fma9639 |
T67531 | 984-992 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T82844 | 1133-1137 | Body_part | denotes | IL-1 | http://purl.org/sig/ont/fma/fma86583 |
T26270 | 1444-1452 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 738-747 | Body_part | denotes | epithelia | http://purl.obolibrary.org/obo/UBERON_0000483 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T77 | 266-274 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T78 | 321-329 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T79 | 345-354 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T80 | 953-961 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T81 | 1197-1209 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T82 | 1222-1230 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T83 | 1472-1480 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T84 | 1759-1767 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T46300 | 201-202 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T30392 | 304-310 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
T99176 | 731-737 | http://purl.obolibrary.org/obo/UBERON_0001005 | denotes | airway |
T92879 | 847-856 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T54720 | 867-875 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | actively |
T62975 | 1014-1024 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T55060 | 1146-1148 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T96273 | 1270-1274 | http://purl.obolibrary.org/obo/CLO_0053704 | denotes | IL-8 |
T33585 | 1339-1341 | http://purl.obolibrary.org/obo/CLO_0007074 | denotes | kB |
T27677 | 1339-1341 | http://purl.obolibrary.org/obo/CLO_0051988 | denotes | kB |
T80865 | 1353-1355 | http://purl.obolibrary.org/obo/CLO_0001022 | denotes | Li |
T85633 | 1353-1355 | http://purl.obolibrary.org/obo/CLO_0007314 | denotes | Li |
T17975 | 1507-1508 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T96342 | 1581-1582 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T44 | 688-698 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
T45 | 984-992 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T46 | 1133-1135 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T48 | 1143-1145 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T50 | 1261-1263 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T52 | 1270-1272 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T54 | 1336-1338 | Chemical | denotes | NF | http://purl.obolibrary.org/obo/CHEBI_141424|http://purl.obolibrary.org/obo/CHEBI_25573|http://purl.obolibrary.org/obo/CHEBI_1224 |
T57 | 1353-1355 | Chemical | denotes | Li | http://purl.obolibrary.org/obo/CHEBI_30145 |
T58 | 1635-1644 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T9 | 1444-1458 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T62 | 847-856 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T63 | 1120-1129 | http://purl.obolibrary.org/obo/GO_0046903 | denotes | secretion |
T64 | 1197-1209 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T65 | 1270-1285 | http://purl.obolibrary.org/obo/GO_0032637 | denotes | IL-8 production |
T66 | 1662-1675 | http://purl.obolibrary.org/obo/GO_0045087 | denotes | innate immune |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
414 | 723-727 | Gene | denotes | ACE2 | Gene:59272 |
415 | 1133-1138 | Gene | denotes | IL-1β | Gene:3552 |
416 | 1143-1148 | Gene | denotes | IL-18 | Gene:3606 |
417 | 1233-1237 | Gene | denotes | NSP9 | Gene:43740578 |
418 | 1242-1247 | Gene | denotes | NSP10 | Gene:43740578 |
419 | 1261-1265 | Gene | denotes | IL-6 | Gene:3569 |
420 | 1270-1274 | Gene | denotes | IL-8 | Gene:3576 |
421 | 1316-1320 | Gene | denotes | NKRF | Gene:55922 |
422 | 1117-1119 | Gene | denotes | to | Gene:6999 |
423 | 763-765 | Gene | denotes | to | Gene:6999 |
424 | 377-379 | Gene | denotes | to | Gene:6999 |
425 | 129-133 | Species | denotes | CoVs | Tax:11118 |
426 | 321-329 | Species | denotes | SARS-CoV | Tax:694009 |
427 | 832-836 | Species | denotes | CoVs | Tax:11118 |
428 | 953-961 | Species | denotes | SARS-CoV | Tax:694009 |
429 | 1222-1232 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
430 | 1481-1489 | Species | denotes | patients | Tax:9606 |
431 | 266-274 | Disease | denotes | COVID-19 | MESH:C000657245 |
432 | 336-354 | Disease | denotes | MERS-CoV infection | MESH:D018352 |
433 | 1197-1209 | Disease | denotes | inflammation | MESH:D007249 |
434 | 1472-1480 | Disease | denotes | COVID-19 | MESH:C000657245 |
435 | 1759-1767 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T67 | 0-57 | Sentence | denotes | Imbalance between Antiviral and Proinflammatory Responses |
T68 | 58-289 | Sentence | denotes | Taken together, the multiplicity of strategies developed by pathogenic CoVs to escape immune sensing, particularly the IFN-I pathway, suggests a critical role played by the dysregulation of IFN-I response in COVID-19 pathogenicity. |
T69 | 290-481 | Sentence | denotes | Concordantly, animal models of SARS-CoV-1 and MERS-CoV infection indicate that failure to elicit an early IFN-I response correlates with the severity of disease (Channappanavar et al., 2016). |
T70 | 482-679 | Sentence | denotes | Perhaps more importantly, these models demonstrate that timing is key, as IFN is protective early in disease but later becomes pathologic (Channappanavar et al., 2016, Channappanavar et al., 2019). |
T71 | 680-801 | Sentence | denotes | Perhaps interferon-induced upregulation of ACE2 in airway epithelia may contribute to this effect (Ziegler et al., 2020). |
T72 | 802-938 | Sentence | denotes | Furthermore, while pathogenic CoVs block IFN signaling, they may actively promote other inflammatory pathways contributing to pathology. |
T73 | 939-1210 | Sentence | denotes | For instance, SARS-CoV-1 ORF3a, ORF8b, and E proteins enhance inflammasome activation (Chen et al., 2019, Nieto-Torres et al., 2015, Shi et al., 2019, Siu et al., 2019), leading to secretion of IL-1β and IL-18, which are likely to contribute to pathological inflammation. |
T74 | 1211-1371 | Sentence | denotes | Similarly, SARS-CoV-2 NSP9 and NSP10 might induce IL-6 and IL-8 production, potentially by inhibition of NKRF, an endogenous NF-kB repressor (Li et al., 2020a). |
T75 | 1372-1564 | Sentence | denotes | Collectively, these proinflammatory processes likely contribute to the “cytokine storm” observed in COVID-19 patients and substantiate a role for targeted immunosuppressive treatment regimens. |
T76 | 1565-1768 | Sentence | denotes | Moving forward, a clear understanding of the delicate balance between antiviral and inflammatory innate immune programs will be essential to developing effective biomarkers and therapeutics for COVID-19. |